CD8A and neoplasm: Moreover, the OVA‐pulsed DC‐derived EVs exhibit a stronger stimulatory effect than engineered TDEVs in the induction of OVA‐specific CD8+ T cell responses and antitumor immunity, and both of them showed tumor targeting ability.166